The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|May 14, 2014
Equipment and Processing Report
- Equipment and Processing Report-05-21-2014
- Volume 0
- Issue 0
System Improves Vial Drying and Handling
Author(s)Pharmaceutical Technology Editors
Garvey's vial-drying system and pressure-less accumulator reduces drying time and decreases the risk of vial damage.
Advertisement
Garvey Corp. has developed patented solutions to vial-handling problems. The Vial Drying System uses a conveyor to pull moisture from vials arriving from cold storage. Vials can be dried and brought to room temperature in minutes, rather than the hours of time typical for conventional drying on trays. The drying system is mated with the Infinity Accumulator, which uses pressure-less filing to send the vials in single-file or multiple lanes at rates up to 800 vials per minute for feeding into a filler or labeling system.
Articles in this issue
over 12 years ago
Evaluating Facility cGMP Compliance By Reviewing Gowning Practicesover 12 years ago
Continuous Solid-Dosage Manufacturing Moves Forwardover 12 years ago
Packaging Innovations Displayed at INTERPHEX 2014Advertisement
Related to this article
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AI Formulation: Regulators Want Data
2
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
3
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
4
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
5